jeff sharman, md, shares results of the genuine phase 2 study presented at asco 2017
Published 7 years ago • 16 plays • Length 1:34
Download video MP4
Download video MP3
Similar videos
-
3:58
prof. jeff sharman: results of the phase iii genuine study
-
1:23
jeff sharman, md, comments on emerging trends in cll management
-
2:08
asj editor's choice with jeff kenkel, md and yucel akgul, md
-
8:59
dr. jeff sharman on qol with obinutuzumab and bendamustine for 1st-line cll at ash 2017
-
7:07
healthcare professional knowledge of cll treatments - dr. jeff sharman ash 2023
-
7:28
egfrm nsclc: should we treat with durvalumab? - asco lung review 2022
-
59:13
measuring als by dr. jeremy shefner
-
1:01:29
chronic lymphocytic leukemia: applying the latest evidence with btk inhibitors to decision making
-
17:13
chronic lymphocytic leukemia treatment & side effects (venetoclax & obinutuzumab) | tamsin (3 of 3)
-
2:08
understanding the loss of skin elasticity and its impact on facelift results | dr. ramsey j choucair
-
1:42
jeff sharman, md, on the outcomes of captivate study investigating ibrutinib and venetoclax
-
0:56
differential when thinking about cll | dr. jeff sharman | oncology brothers #2023
-
0:46
daniel lin, md | advances on gastrointestinal cancers at 2019 asco direct highlights philadelphia
-
1:33
dr. jeff sharman shares successes of clinical trials happening at wvci
-
1:39
jeff sharman, md, offers perspective on car t-cell therapies for the treatment of nhl
-
2:21
christopher yasenchak, md, on 1st line brentuximab vedotin nivolumab in hodgkin’s lymphoma
-
1:42
asj article highlight steven r cohen, md
-
1:09
dr. sharman on unmet clinical needs in high-risk relapsed/refractory cll
-
0:59
results of the metgastric study
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
0:49
front-line treatment options for cll | dr. jeff sharman | oncology brothers #2023
-
1:07
asco 2017 : advances in cancer research
Clip.africa.com - Privacy-policy